Healthcare Pharmaceutical Biotech

TRNR Updates FAQs, With a More Than 50% Quarterly Revenue Increase Expected in Q2 From Q1

June 17, 2026 12:55 PM

Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today announced it had updated its FAQs, highlighting the expected increase in quarterly revenue by more than 50% in Q2 from Q1, the 2026 pro forma revenue guidance of more than $30 million, expectation to be run-rate profitable by year-end, additional potential acquisitions and...

Read more

Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean

June 17, 2026 10:45 AM

Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) is pleased to announce that it has entered into a formal agreement for its drug treatments for prostate conditions, with the Global Alliance of Regenerative Medicine (GARM) on Roatan Island in the Western Caribbean. Nymox's Nymozarfex (TM) which is owned and developed by Nymox, will be offered and available to men to improve their prostate health and to treat prostate...

Read more

Keena Healthcare Technology Transitions to Employee Ownership Through ESOP

June 17, 2026 10:30 AM

Keena Healthcare Technology, a full-service healthcare IT company specializing in EHR integrations, data conversions, document management, and clinical workflow solutions, today announced the formation of an Employee Stock Ownership Plan (ESOP), transitioning 100% ownership of the company to its employees. An ESOP is an employee benefit plan that enables team members to hold an ownership stake in the company they work for, building long-term...

Read more

Snapshot Recipes AI Turns Refrigerator Photos Into Personalized Recipes From Virtually Any Cuisine

June 17, 2026 9:17 AM

Medical Care Technologies, Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), an artificial intelligence and software development company, today announced expanded marketing initiatives for Snapshot Recipes, the Company's flagship AI-powered mobile application that allows users to create customized recipes simply by taking a photo of groceries, ingredients, or the contents of their refrigerator. Learn more at www.snapshotrecipes.app Snapshot...

Read more

Aetna Better Health of Missouri Collaborates With Community-Focused Organizations To Expand Access to Maternal Care in Rural Communities

June 17, 2026 9:00 AM

Aetna Better Health of Missouri, a CVS Health company (NYSE:CVS), today announced a new collaboration with community-focused organizations to improve maternal health and women's health outcomes in rural Missouri. Through a $720,000 commitment made by Aetna via the Global Mobile Healthcare Research Consortium (GMHRC), the initiative will bring mobile women's care services and connection to maternal health services directly to communities in...

Read more

Managing Graft Versus Host Disease in Stem Cell Transplant Care

June 17, 2026 8:35 AM

Stem cell transplantation is an important treatment option for many serious blood disorders, immune system conditions, and bone marrow diseases. While the procedure can offer life-changing benefits, it also requires careful medical monitoring because complications may occur after transplant. One of the most important complications patients and families should understand is graft versus host disease. Graft versus host disease, often called GVHD,...

Read more

MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy

June 17, 2026 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced the submission of a Phase 2a clinical trial protocol to the U.S. Food and Drug Administration (FDA) for Ketamir-2, the Company's proprietary oral NMDA receptor modulator, in chemotherapy-induced peripheral neuropathy (CIPN). Addressing...

Read more

Ceiba Health Launches Befour Scale Integration Across 20+ Electronic Medical Records

June 17, 2026 8:00 AM

Ceiba Health today announced the launch of its powerful new Befour (Saukville, Wisconsin) digital scale integration, the latest expansion of its industry-leading eConnect interoperability platform. Now compatible with more than 20 electronic medical record systems, this new offering gives health systems a seamless, fully connected solution for capturing and documenting patient weight data with zero manual intervention. By bridging the gap...

Read more

A New Era in Aplastic Anemia Treatment with Stem Cell Transplantation

June 17, 2026 7:15 AM

Aplastic anemia is a rare but serious blood disorder that develops when the bone marrow fails to produce enough blood cells. Because red blood cells, white blood cells, and platelets are all affected, patients can experience a wide range of symptoms that significantly impact their daily lives. While the condition was once associated with limited treatment options, advances in stem cell transplantation have transformed the outlook for many...

Read more

Moderna to Host Investor Event - Science Day

June 17, 2026 7:00 AM

Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Science Day at 9:00am ET on Thursday, June 25, 2026. The event will feature an overview of Moderna's research and early development programs, highlighting how the Company's mRNA platform, together with advances in AI and robotics, is accelerating innovation and creating opportunities to expand into new therapeutic areas. A live webcast of the presentation will be...

Read more

Stem Cell Transplantation in the Treatment of Lymphocytic Leukemia

June 17, 2026 6:50 AM

Lymphocytic leukemia is a type of blood cancer that affects lymphocytes, a group of white blood cells that play a crucial role in the body's immune system. When these cells grow abnormally and accumulate in the blood, bone marrow, and lymphatic tissues, they can interfere with the production of healthy blood cells and weaken the body's ability to fight infections. Over the past several decades, advances in medical research have significantly...

Read more

CTT Pharma Signs LOI with European Company

June 17, 2026 6:00 AM

CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a company in the United States to conduct clinical trials and testing for several potential nicotine products for CTT Pharma. A partnership with this company would allow CTT the ability to independently go to market in the United States utilizing our patented technology. CTT Pharma will notify shareholders as more information becomes available. About CTT Pharmaceutical...

Read more

Genflow Biosciences PLC - Company to present at Animal Longevity Summit 2026

June 17, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, today announces that it has been invited to present data from its SLAB (Sarcopenia and Longevity in Aged Beagles) clinical study at the Animal Longevity Summit ("ALOS"), taking place in Toronto, Canada, on 1-2 October 2026. The SLAB study is designed to evaluate the potential of Genflow's centenarian SIRT6 gene...

Read more

Former DEA Section Chief Steps Forward to Challenge Marijuana Rescheduling Process

June 17, 2026 12:50 AM

As the Drug Enforcement Administration prepares for its June 29 marijuana rescheduling hearing, an unusual group of experts is emerging to challenge the government's approach. They are not politicians. They are not cannabis activists. They are not industry lobbyists. Instead, they are individuals whose careers were spent enforcing drug laws, developing FDA-regulated medicines, and protecting public health. Among them is Jorge Jimenez, a...

Read more

Shiny Smile Veneers Reviews and Complaints 2026: The $90 Refund Deduction Explained, the 60-Day Guarantee Conditions Most Buyers Miss, and What to Verify Before Ordering

June 16, 2026 7:55 PM

Advertorial | Affiliate links are present in this article. If you purchase through one, a commission may be earned at no extra cost to you. This article covers a commercially available cosmetic dental product and is intended for consumer education. Not dental advice - consult a licensed dentist if you have any active oral health concerns. The "$90 Deduction" and "60-Day Guarantee" phrases in the title refer to financial terms published in Shiny...

Read more

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

June 16, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated November 18, 2025, the completion of its pilot project with Kuano Ltd. ("Kuano"), supporting the continued advancement of Onco's PNKP Inhibitor Technology (also known as ONC010) through advanced AI-enabled and quantum-based computational approaches. Kuano has completed the project...

Read more

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

June 16, 2026 4:15 PM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications including wound care, eye care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced financial results for fiscal year 2026 and the fourth quarter ended March 31, 2026. "Fiscal 2026 was a...

Read more

Protagonist Therapeutics Reports Granting of Inducement Awards

June 16, 2026 4:00 PM

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on June 15, 2026, it granted inducement awards to three recently hired employees in accordance with the terms of their employment offer letters. The awards were granted under the Protagonist Therapeutics Amended and Restated Inducement Plan, which was adopted May 29, 2018, and amended February 18, 2020 and February 15, 2022. The new employees received, in the aggregate, options to...

Read more

Shed GLP-1 Review 2026 Explores Updated Guarantee, Foundayo Approval, Dose-Escalation Pricing, and Key Buyer Questions

June 16, 2026 2:10 PM

ShedRx: Shed GLP-1 Research 2026: Updated Guarantee, Foundayo Approval, the FDA's June 29 Compounding Deadline, and What to Verify Before Enrolling Advertorial Disclosure: This is promotional content with affiliate links - if you enroll through a link in this article, a commission may be earned at no extra cost to you, per FTC 16 CFR Part 255. That relationship doesn't change what's written here. Shed is a telehealth platform; licensed...

Read more

RightWell GLP-1 Review 2026: Is the $159 Compounded GLP-1 Program With a 10% Guarantee Worth It?

June 16, 2026 2:05 PM

Advertorial | Telehealth Platform Disclosure: RightWell is a technology platform operated by Prescribey, Inc. It doesn't practice medicine, employ clinicians, or prescribe medication. All prescribing is performed independently by a licensed medical practice (the "Practice") whose licensed providers make every clinical decision. Compounded medications are prepared and dispensed by certified U.S.-licensed pharmacy partners - separate entities from...

Read more